APPLICATION OF α1-ADRENOBLOCKERS IN TREATMENT OF URETERAL CALCULI


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The results of evaluation of the efficacy of α1-adrenoblockers in treatment of ureteral calculi are presented. Comparative, prospective, placebo-uncontrolled nonrandomized single-center study was performed, which included 118 patients with solitary diagnosed calculi in various parts of ureter. After the pain relief, all the patients underwent conservative therapy aimed at spontaneous discharge of concretions. The maximum duration of conservative treatment was 28 days. Ultrasound monitoring was performed every week in all patients. The control group of patients received only Drotaverinum 40 mg three times a day, and analgesics. The main group received α1-adrenoblocker tamsulosin at a standard dose of 0.4 mg once a day along with Drotaverinum and analgesics. The overall probability of a discharge of concrements localized in the distal ureter was significantly (P=0.02) higher in the patients treated with α1-adrenoblockers. Treatment regimen in main group of patients allowed better control of pain during all periods of observation, even if the discharge of concretions was not registered. The overall probability of migration of concrements from the proximal to the distal ureter in main group of patients was 52% versus 32% in controls (P=0.17). The frequency of adverse effects was comparable in both groups. Vertigo, postural hypotension, and weakness were significantly more frequent in the main group of patients. Univariate and multivariate analyses of the proportional hazards model have demonstrated that the administration of a1-adrenoblocker increased the likelihood of a discharge of concrement from the distal ureter. It is shown that the nature of the applied therapy has directly influence on the risk of an earlier discharge of concretions. Inclusion of α1-adrenoblockers in the treatment scheme increased the probability of discharge of concrements at 4.11 times.

Full Text

Restricted Access

References

  1. Kaid-Omar Z., Belouatek A., Driouch A. et al. Effects of diuretic therapy on spontaneous expulsion of urinary calculi, urinary pH, and crystalluria in lithiasic patients. Prog. Urol. 2001;11:450-454.
  2. Worster A., Richards C. Fluids and diuretics for acute ureteric colic. Cochrane Database. Sys. Rev. 2005; CD 004926.
  3. Weiss R. M. Physiology and Pharmacology of the renal pelvis and ureter. In Cambell’s Urology (P. C. Walsh, A. B. Retik, T. A. Stamey, E. D., E. D. Vaughan eds). 7 th edn, Vol. 1, Chapt. 25. Philadelphia: WB Saunders Co., 1999;839-869.
  4. Lang R. J., Hashitani H., Tonta M. A. et al. Spontaneous electrical and Ca2+ signals in typical and atypical smooth muscle cells and interstitial cell of Cajal-like cells of mouse renal pelvis. J. Physiol. 2007;583:1049-1068.
  5. Lang R. J., Tonta M. A., Beata Z. Zolotkowski et al. Pyeloureteric peristalsis: role of atypical smooth muscle cells and interstitial cells of Cajal-like cells as pacemakers. J. Physiol. 2006;576:695-705.
  6. Lang R. J., Tonta M. A., Beata Z. Zolotkowski et al. Pyeloureteric peristalsis: role of atypical smooth muscle cells and interstitial cells of Cajal-like cells as pacemakers. J. Physiol. 2006;576:695-705.
  7. Rose J. G., Gillenwater J. Y. The effect of adrenergic and cholinergic agents and their blockers upon ureteral activity. Invest. Urol. n1974;11:439—441.
  8. Ross J. A., Edmond P., Griffiths J. M. The action of drugs on the intact human ureter. Br. J. Urol. 1967;39:26-29.
  9. Sigala S., Dellabella M., Milanese G. Evidence for the presence of alpha1-adrenoceptor subtypes in the human ureter. Neurourol. Urodyn. 2005;24:142-148.
  10. Hyoung K. P., Eun Y. C., Byong C. J. et al. Localizations and expressions of α1A, α1-1B and α1-1D adrenoceptors in human ureter. Urol. Res. 2007;35:325-329.
  11. O’Leary M. P. Tamsulosin (current clinical experience). Urology. 2001;58(Suppl. 6):42-48.
  12. Hartrick C. T., Kovan J. P., Shapiro S. The numeric rating scale for clinical pain measurement: a ratio measure? Pain. Pract. 2003;3(4):310-316.
  13. Griffiths D. J. The mechanics of urine transport in the upper urinary tract. 2. The discharge of the bolus into the bladder and dynamics at high rates of flow. Neurourol. Urodyn. 1983;2:167-177.
  14. Crowley A. R., Byrne J. C., Vaughan Jr. E. D. et al. The effect of acute obstruction on ureteral function. J. Urol. 1990;143:596-599.
  15. Gasser H. S., Grundfest H. Axon diameters in relation to the spike dimensions and the conduction velocity in mammalian A-fibers. Amer. J. Physiol. 1939;127:393-397.
  16. Dixon J. S., Gosling J. A. The musculature of the human renal calices, pelvis and upper ureter. J. Anatomy. 1973;135:129-137.
  17. McLeod D. G., Reynolds D. G., Swan R. G. Adrenergic mechanisms in the canine ureter. Am. J. Physiol. 1973;224:1054-1059.
  18. Davenport K., Timoney A. G., Keeley F. X. A comparative in vitro study to determine the beneficial effect of calcium-channel and a1-adrenoceptor antagonism on human ureteric activity. B.J.U. Int. 2006;98(3):651-655.
  19. Davenport K., Timoney A. G., Keeley Jr F. X. Effect of smooth muscle relaxant drugs on proximal human ureteric activity in vivo: a pilot study. Urol. Res. 2007;35:207-213.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2012 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies